11 July 2019
IXICO plc
("IXICO" or the "Company")
Director and PDMR share purchase
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 July 2019 that on 05 July 2019 and 09 July 2019 Charles Spicer, Chairman of the Company, acquired 140,421 ordinary shares at an average price of 28.485p.
Charles Spicer is interested in 333,196 Ordinary Shares, representing 0.71 per cent of the enlarged issued share capital of the Company following the purchase.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Name |
Charles Spicer |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Chairman |
|||
|
b) |
Initial notification /Amendment |
Initial notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
IXICO plc |
|||
|
b) |
LEI |
2138005M1F59O6HWSA97 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares in IXICO plc |
|||
|
Identification code |
GB00BCLY7L40 |
||||
|
b) |
Nature of the transaction |
Acquisition |
|||
|
c) |
Price(s) and volume(s) |
||||
|
Price(s) |
Volume(s) |
||||
|
5/7/19 |
|||||
|
29.499p |
33,899 |
||||
|
29p |
34,482 |
||||
|
29p |
34,482 |
||||
|
9/7/19 |
|||||
|
26.625p |
37,558 |
||||
|
d) |
Aggregated information |
||||
|
- Aggregated volume |
140,421 shares |
||||
|
- Price |
28.485p |
||||
|
e) |
Date of the transaction |
5/7/19 and 9/7/19 |
|||
|
f) |
Place of the transaction |
London Stock Exchange, AIM Market (IXI), UK |
|||
|
IXICO plc |
+44 (0) 20 3763 7498 |
|
Giulio Cerroni, Chief Executive Officer |
|
|
Cenkos Securities PLC (Nominated adviser and sole broker) |
+44 (0) 20 7397 8900 |
|
Giles Balleny / Max Gould (Corporate Finance) |
|
|
Michael F Johnson / Russell Kerr (Sales) |
|
|
Optimum Strategic Communications |
+44 (0) 203 950 9144 |
|
Mary Clark / Anne Marieke Ezendam / Supriya Mathur |
|
|
ixico@optimumcomms.com |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.